CVS Health Corp (BSP:CVSH34)
R$ 31.75 -0.09 (-0.28%) Market Cap: 403.33 Bil Enterprise Value: 794.75 Bil PE Ratio: 9.69 PB Ratio: 0.92 GF Score: 76/100

CVS Health Corp at Goldman Sachs Global Healthcare Conference Transcript

Jun 15, 2022 / 03:00PM GMT
Release Date Price: R$45.92 (-1.10%)
Lindsay Sara Golub
Goldman Sachs Group, Inc., Research Division - Research Analyst

Good morning. My name is Lindsay Golub. I work on the healthcare services team at Goldman Sachs, and we're pleased to have you all here with us today in California. I have Shawn Guertin with us from CVS. We're very pleased to have them here.

Shawn Michael Guertin
CVS Health Corporation - Executive VP & CFO

Thank you. Good morning, everyone.

Lindsay Sara Golub
Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. So just before we start, just have to make some quick disclosures. We're required to make certain disclosures in public appearances about Goldman Sachs' relationships with companies that we discuss. The disclosures relate to investment banking relationships, compensation received or 1% or more ownership. We are prepared to read aloud disclosures for any issuer upon request. However, these disclosures are available in our most recent reports available to you as clients on our firm's portals. These

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot